| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myopathies, Structural, Congenital | 42 | 2023 | 102 | 10.340 |
Why?
|
| Myopathies, Nemaline | 36 | 2021 | 72 | 5.670 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 22 | 2022 | 66 | 4.080 |
Why?
|
| Muscle Proteins | 39 | 2024 | 1159 | 3.000 |
Why?
|
| Muscle, Skeletal | 88 | 2024 | 4933 | 2.980 |
Why?
|
| Actinin | 23 | 2021 | 160 | 2.440 |
Why?
|
| Muscular Diseases | 23 | 2024 | 557 | 2.340 |
Why?
|
| Muscular Dystrophies | 32 | 2019 | 393 | 2.230 |
Why?
|
| Sarcomeres | 13 | 2021 | 374 | 1.990 |
Why?
|
| Anemia, Diamond-Blackfan | 12 | 2018 | 137 | 1.850 |
Why?
|
| Zebrafish | 22 | 2024 | 2990 | 1.770 |
Why?
|
| Mutation | 78 | 2024 | 29717 | 1.330 |
Why?
|
| Tropomyosin | 6 | 2015 | 102 | 1.250 |
Why?
|
| Neonatal Screening | 10 | 2023 | 591 | 1.230 |
Why?
|
| Ribosomal Proteins | 10 | 2018 | 360 | 1.230 |
Why?
|
| Myofibrils | 7 | 2016 | 146 | 1.180 |
Why?
|
| Cofilin 2 | 5 | 2020 | 12 | 1.150 |
Why?
|
| Swimming | 3 | 2023 | 206 | 1.090 |
Why?
|
| Muscle Fibers, Skeletal | 16 | 2021 | 555 | 1.060 |
Why?
|
| Genetic Testing | 19 | 2023 | 3439 | 1.060 |
Why?
|
| Mutation, Missense | 16 | 2017 | 2556 | 1.030 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 1004 | 1.020 |
Why?
|
| Genetic Diseases, X-Linked | 5 | 2023 | 370 | 1.010 |
Why?
|
| Actins | 25 | 2024 | 2120 | 0.980 |
Why?
|
| Selenoproteins | 5 | 2020 | 216 | 0.970 |
Why?
|
| Activin Receptors, Type II | 3 | 2016 | 127 | 0.950 |
Why?
|
| Dystrophin | 25 | 2005 | 285 | 0.940 |
Why?
|
| Microfilament Proteins | 13 | 2024 | 1152 | 0.850 |
Why?
|
| Cardiac Myosins | 2 | 2019 | 117 | 0.790 |
Why?
|
| Neuromuscular Diseases | 6 | 2019 | 253 | 0.760 |
Why?
|
| Phenotype | 50 | 2024 | 16331 | 0.710 |
Why?
|
| Muscle Weakness | 8 | 2023 | 414 | 0.710 |
Why?
|
| Muscles | 17 | 2024 | 1617 | 0.690 |
Why?
|
| Myosin Light Chains | 1 | 2019 | 121 | 0.690 |
Why?
|
| Point Mutation | 8 | 2018 | 1624 | 0.670 |
Why?
|
| Laminin | 3 | 2012 | 418 | 0.630 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 2566 | 0.630 |
Why?
|
| Cardiomyopathy, Dilated | 5 | 2018 | 851 | 0.620 |
Why?
|
| Exons | 14 | 2023 | 2431 | 0.590 |
Why?
|
| Genetic Association Studies | 12 | 2019 | 2699 | 0.580 |
Why?
|
| RNA, Ribosomal | 4 | 2018 | 246 | 0.580 |
Why?
|
| Disease Models, Animal | 23 | 2022 | 18006 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 18 | 2023 | 17400 | 0.580 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2014 | 124 | 0.560 |
Why?
|
| Muscular Dystrophy, Duchenne | 7 | 2021 | 256 | 0.540 |
Why?
|
| Pedigree | 29 | 2019 | 4646 | 0.530 |
Why?
|
| Long QT Syndrome | 6 | 2002 | 453 | 0.520 |
Why?
|
| X Chromosome | 9 | 2012 | 815 | 0.500 |
Why?
|
| Dog Diseases | 2 | 2015 | 136 | 0.470 |
Why?
|
| Hypertrichosis | 1 | 2013 | 25 | 0.470 |
Why?
|
| KATP Channels | 1 | 2013 | 45 | 0.460 |
Why?
|
| Infant | 48 | 2023 | 35070 | 0.460 |
Why?
|
| Muscle Fibers, Slow-Twitch | 5 | 2016 | 49 | 0.450 |
Why?
|
| Infant, Newborn | 31 | 2023 | 25575 | 0.450 |
Why?
|
| Child, Preschool | 52 | 2023 | 40955 | 0.440 |
Why?
|
| Muscle Strength | 4 | 2023 | 586 | 0.440 |
Why?
|
| Neurofilament Proteins | 1 | 2014 | 318 | 0.430 |
Why?
|
| Child | 70 | 2023 | 77478 | 0.430 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2013 | 78 | 0.430 |
Why?
|
| Frameshift Mutation | 4 | 2013 | 399 | 0.430 |
Why?
|
| Osteochondrodysplasias | 1 | 2013 | 183 | 0.420 |
Why?
|
| Humans | 235 | 2024 | 742088 | 0.420 |
Why?
|
| Parents | 9 | 2022 | 3387 | 0.420 |
Why?
|
| Muscle Contraction | 10 | 2018 | 1241 | 0.420 |
Why?
|
| Animals | 81 | 2024 | 168561 | 0.410 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 474 | 0.410 |
Why?
|
| Protein Isoforms | 11 | 2018 | 1727 | 0.410 |
Why?
|
| Myoblasts | 4 | 2018 | 238 | 0.410 |
Why?
|
| Base Sequence | 26 | 2017 | 12797 | 0.400 |
Why?
|
| Dystroglycans | 2 | 2011 | 60 | 0.400 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 209 | 0.400 |
Why?
|
| Genes, Dominant | 7 | 2012 | 880 | 0.380 |
Why?
|
| Abnormalities, Multiple | 4 | 2012 | 1416 | 0.380 |
Why?
|
| Cardiomegaly | 1 | 2013 | 619 | 0.370 |
Why?
|
| Ophthalmoplegia | 4 | 1998 | 166 | 0.370 |
Why?
|
| Male | 128 | 2024 | 349538 | 0.370 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 2126 | 0.370 |
Why?
|
| Distal Myopathies | 2 | 2024 | 16 | 0.370 |
Why?
|
| Rare Diseases | 3 | 2021 | 554 | 0.360 |
Why?
|
| Health | 2 | 2019 | 390 | 0.360 |
Why?
|
| Gene Deletion | 7 | 2018 | 2751 | 0.350 |
Why?
|
| DNA Copy Number Variations | 8 | 2024 | 1940 | 0.350 |
Why?
|
| Sudden Infant Death | 2 | 2009 | 291 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 1 | 6 | 2002 | 657 | 0.340 |
Why?
|
| Carrier Proteins | 5 | 2018 | 5019 | 0.340 |
Why?
|
| Premature Birth | 2 | 2019 | 1713 | 0.340 |
Why?
|
| Ubiquitination | 1 | 2013 | 1011 | 0.330 |
Why?
|
| Drug Discovery | 4 | 2023 | 1057 | 0.330 |
Why?
|
| Mice | 40 | 2022 | 81045 | 0.320 |
Why?
|
| INDEL Mutation | 1 | 2009 | 279 | 0.320 |
Why?
|
| Genomics | 11 | 2023 | 5692 | 0.320 |
Why?
|
| Genes | 5 | 2003 | 1892 | 0.320 |
Why?
|
| Dynamin II | 4 | 2013 | 35 | 0.320 |
Why?
|
| Proteins | 2 | 2013 | 6096 | 0.320 |
Why?
|
| Genetic Linkage | 12 | 2015 | 2422 | 0.310 |
Why?
|
| Sequence Analysis, DNA | 10 | 2019 | 4801 | 0.310 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 473 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 16 | 2011 | 6171 | 0.310 |
Why?
|
| Dependovirus | 5 | 2021 | 706 | 0.300 |
Why?
|
| Gene Expression Profiling | 14 | 2019 | 9410 | 0.300 |
Why?
|
| Mice, Knockout | 15 | 2020 | 14554 | 0.290 |
Why?
|
| Nuclear Proteins | 5 | 2018 | 5851 | 0.290 |
Why?
|
| Cell Cycle | 5 | 2019 | 2964 | 0.290 |
Why?
|
| Thumb | 1 | 2008 | 226 | 0.290 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 1452 | 0.290 |
Why?
|
| Blotting, Western | 11 | 2016 | 5180 | 0.280 |
Why?
|
| Sodium Channels | 3 | 2010 | 349 | 0.280 |
Why?
|
| Genotype | 18 | 2023 | 12946 | 0.270 |
Why?
|
| DNA Mutational Analysis | 18 | 2017 | 4187 | 0.270 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1873 | 0.270 |
Why?
|
| Heterozygote | 9 | 2023 | 2790 | 0.270 |
Why?
|
| Molecular Sequence Data | 30 | 2014 | 18112 | 0.270 |
Why?
|
| Databases, Genetic | 9 | 2021 | 1780 | 0.270 |
Why?
|
| Potassium Channels | 3 | 1998 | 562 | 0.270 |
Why?
|
| Psychotic Disorders | 4 | 2023 | 3040 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 1997 | 462 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.260 |
Why?
|
| Female | 101 | 2021 | 379592 | 0.260 |
Why?
|
| Blepharoptosis | 3 | 1998 | 144 | 0.250 |
Why?
|
| Genetic Variation | 12 | 2019 | 6540 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2010 | 3920 | 0.250 |
Why?
|
| Truth Disclosure | 2 | 2019 | 435 | 0.250 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1699 | 0.250 |
Why?
|
| Transcription Factors | 6 | 2021 | 12164 | 0.240 |
Why?
|
| Chromosome Mapping | 21 | 2021 | 4742 | 0.240 |
Why?
|
| Amino Acid Sequence | 19 | 2021 | 13814 | 0.240 |
Why?
|
| Cytoskeletal Proteins | 5 | 2018 | 1363 | 0.240 |
Why?
|
| Transcription, Genetic | 7 | 2006 | 7721 | 0.240 |
Why?
|
| Genes, Recessive | 8 | 2013 | 642 | 0.230 |
Why?
|
| Signal Transduction | 9 | 2021 | 23387 | 0.230 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2012 | 428 | 0.230 |
Why?
|
| Contractile Proteins | 2 | 2003 | 246 | 0.230 |
Why?
|
| Chromosome Deletion | 10 | 2016 | 1400 | 0.230 |
Why?
|
| Genetic Counseling | 2 | 2018 | 600 | 0.230 |
Why?
|
| Genome, Human | 6 | 2023 | 4420 | 0.230 |
Why?
|
| Larva | 2 | 2023 | 517 | 0.220 |
Why?
|
| Cleft Palate | 1 | 2008 | 558 | 0.220 |
Why?
|
| Dogs | 8 | 2017 | 3910 | 0.220 |
Why?
|
| Longevity | 1 | 2011 | 1069 | 0.220 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 587 | 0.220 |
Why?
|
| Genetic Heterogeneity | 3 | 2015 | 732 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2016 | 355 | 0.220 |
Why?
|
| Hypophosphatemia | 1 | 2023 | 85 | 0.210 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2014 | 209 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 3585 | 0.210 |
Why?
|
| DNA Primers | 7 | 2012 | 2892 | 0.210 |
Why?
|
| Actomyosin | 1 | 2023 | 111 | 0.210 |
Why?
|
| GATA1 Transcription Factor | 2 | 2014 | 293 | 0.210 |
Why?
|
| Gene Expression Regulation | 13 | 2021 | 12071 | 0.210 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2018 | 375 | 0.210 |
Why?
|
| RNA, Messenger | 14 | 2020 | 13029 | 0.210 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 2014 | 158 | 0.210 |
Why?
|
| Biopsy | 17 | 2019 | 6756 | 0.200 |
Why?
|
| Sequence Deletion | 4 | 2012 | 1526 | 0.200 |
Why?
|
| Muscle Fibers, Fast-Twitch | 5 | 2016 | 69 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2948 | 0.200 |
Why?
|
| JC Virus | 3 | 1994 | 85 | 0.200 |
Why?
|
| Adolescent | 37 | 2023 | 85649 | 0.200 |
Why?
|
| Adult | 58 | 2023 | 213712 | 0.190 |
Why?
|
| Directed Molecular Evolution | 1 | 2021 | 161 | 0.190 |
Why?
|
| Antigens, Viral, Tumor | 3 | 1990 | 154 | 0.180 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 1998 | 141 | 0.180 |
Why?
|
| Glycolysis | 2 | 2009 | 825 | 0.180 |
Why?
|
| Calcium | 7 | 2018 | 5753 | 0.180 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2019 | 176 | 0.180 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2019 | 35 | 0.180 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 142 | 0.180 |
Why?
|
| Models, Molecular | 8 | 2018 | 5454 | 0.180 |
Why?
|
| Gene Expression | 8 | 2018 | 7790 | 0.180 |
Why?
|
| Muscle Development | 3 | 2018 | 271 | 0.170 |
Why?
|
| Myosin Heavy Chains | 3 | 2023 | 414 | 0.170 |
Why?
|
| Age of Onset | 4 | 2019 | 3266 | 0.170 |
Why?
|
| Microscopy, Electron | 4 | 2017 | 2645 | 0.170 |
Why?
|
| Autistic Disorder | 2 | 2021 | 1174 | 0.170 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 165 | 0.170 |
Why?
|
| Troponin T | 2 | 2020 | 749 | 0.170 |
Why?
|
| Capsid | 1 | 2021 | 436 | 0.170 |
Why?
|
| Fatal Outcome | 5 | 2019 | 1849 | 0.170 |
Why?
|
| Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 729 | 0.160 |
Why?
|
| Family | 2 | 2021 | 3144 | 0.160 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2019 | 90 | 0.160 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
| Polyomavirus | 2 | 1990 | 248 | 0.160 |
Why?
|
| Computational Biology | 4 | 2019 | 3518 | 0.160 |
Why?
|
| Eczema | 1 | 2020 | 229 | 0.160 |
Why?
|
| Blotting, Northern | 6 | 2012 | 1581 | 0.160 |
Why?
|
| Sequence Alignment | 5 | 2014 | 2257 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2023 | 3014 | 0.160 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2017 | 40 | 0.150 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2018 | 100 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 9639 | 0.150 |
Why?
|
| Haplotypes | 6 | 2010 | 2781 | 0.150 |
Why?
|
| Myosins | 4 | 2015 | 409 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2017 | 18 | 0.150 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2017 | 55 | 0.150 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2017 | 37 | 0.150 |
Why?
|
| Agrin | 1 | 2017 | 68 | 0.150 |
Why?
|
| Disease Progression | 8 | 2021 | 13256 | 0.150 |
Why?
|
| Hybrid Cells | 4 | 1995 | 441 | 0.150 |
Why?
|
| Oculomotor Nerve | 1 | 1997 | 74 | 0.150 |
Why?
|
| Medulla Oblongata | 2 | 2009 | 243 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2915 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2016 | 30 | 0.140 |
Why?
|
| Oculomotor Muscles | 2 | 1998 | 371 | 0.140 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 339 | 0.140 |
Why?
|
| Lod Score | 8 | 2001 | 615 | 0.140 |
Why?
|
| Apoptosis | 4 | 2015 | 9715 | 0.140 |
Why?
|
| Microcephaly | 1 | 2020 | 430 | 0.140 |
Why?
|
| Cell Line | 13 | 2018 | 15994 | 0.140 |
Why?
|
| Health Care Costs | 2 | 2021 | 3203 | 0.140 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
| Ribosomes | 4 | 2018 | 499 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 1224 | 0.140 |
Why?
|
| Cytoskeleton | 3 | 2021 | 1185 | 0.140 |
Why?
|
| Myokymia | 1 | 2015 | 11 | 0.140 |
Why?
|
| Diaphragm | 2 | 2014 | 347 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 29 | 0.130 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2016 | 80 | 0.130 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 22 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1998 | 417 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 315 | 0.130 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2014 | 464 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 643 | 0.130 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 5 | 2004 | 335 | 0.130 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 17 | 0.130 |
Why?
|
| Genes, BRCA2 | 1 | 2019 | 617 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 4751 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 265 | 0.130 |
Why?
|
| Cation Transport Proteins | 1 | 1998 | 327 | 0.130 |
Why?
|
| Polymorphism, Genetic | 8 | 2012 | 4328 | 0.130 |
Why?
|
| Cataplexy | 1 | 2015 | 60 | 0.130 |
Why?
|
| Dosage Compensation, Genetic | 3 | 1995 | 211 | 0.130 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 497 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 2 | 5 | 2014 | 326 | 0.130 |
Why?
|
| Age Factors | 5 | 2019 | 18355 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 21821 | 0.120 |
Why?
|
| Health Resources | 1 | 2021 | 911 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2012 | 713 | 0.120 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 13 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 1866 | 0.120 |
Why?
|
| Hepatomegaly | 1 | 2014 | 85 | 0.120 |
Why?
|
| Myotonia Congenita | 1 | 2013 | 14 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2019 | 704 | 0.120 |
Why?
|
| Lung | 1 | 2013 | 9826 | 0.120 |
Why?
|
| Escape Reaction | 1 | 2013 | 54 | 0.120 |
Why?
|
| Turkey | 1 | 2014 | 237 | 0.120 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 135 | 0.120 |
Why?
|
| Genetics, Population | 1 | 1999 | 933 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2021 | 2924 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1028 | 0.120 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 824 | 0.120 |
Why?
|
| Codon, Terminator | 4 | 2002 | 127 | 0.120 |
Why?
|
| Gene Order | 1 | 2013 | 176 | 0.120 |
Why?
|
| Ataxia | 1 | 2015 | 304 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1372 | 0.110 |
Why?
|
| Tissue Fixation | 1 | 2014 | 241 | 0.110 |
Why?
|
| Disease | 1 | 2019 | 681 | 0.110 |
Why?
|
| Medical Records | 1 | 2018 | 1413 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 1992 | 768 | 0.110 |
Why?
|
| Expressed Sequence Tags | 2 | 2003 | 255 | 0.110 |
Why?
|
| Young Adult | 14 | 2021 | 56350 | 0.110 |
Why?
|
| Walker-Warburg Syndrome | 1 | 2012 | 14 | 0.110 |
Why?
|
| Myostatin | 2 | 2011 | 124 | 0.110 |
Why?
|
| Genetic Vectors | 4 | 2017 | 3420 | 0.110 |
Why?
|
| Phosphatidylinositols | 1 | 2014 | 291 | 0.110 |
Why?
|
| Kinetics | 3 | 2024 | 6474 | 0.110 |
Why?
|
| Calmodulin | 2 | 2008 | 209 | 0.110 |
Why?
|
| Attitude to Health | 2 | 2019 | 2051 | 0.110 |
Why?
|
| Gait | 2 | 2017 | 784 | 0.110 |
Why?
|
| Immunohistochemistry | 13 | 2018 | 11363 | 0.110 |
Why?
|
| Cell Membrane | 4 | 2012 | 3744 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.110 |
Why?
|
| Pyrazines | 2 | 2021 | 1231 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 350 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 1617 | 0.100 |
Why?
|
| Imidazoles | 2 | 2021 | 1205 | 0.100 |
Why?
|
| Glycosyltransferases | 1 | 2012 | 113 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 1636 | 0.100 |
Why?
|
| Selenocysteine | 1 | 2013 | 124 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1994 | 442 | 0.100 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1988 | 68 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2017 | 3381 | 0.100 |
Why?
|
| Protein Conformation | 4 | 2018 | 4013 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 799 | 0.100 |
Why?
|
| Catalysis | 1 | 2013 | 760 | 0.100 |
Why?
|
| Gene Duplication | 1 | 2012 | 330 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 556 | 0.100 |
Why?
|
| Amino Acid Substitution | 4 | 2013 | 1792 | 0.100 |
Why?
|
| Regeneration | 3 | 2018 | 1485 | 0.100 |
Why?
|
| Schizophrenia | 2 | 2023 | 6874 | 0.100 |
Why?
|
| Gravitation | 1 | 2011 | 82 | 0.100 |
Why?
|
| Gene Frequency | 4 | 2009 | 3587 | 0.100 |
Why?
|
| Peer Review, Research | 1 | 2014 | 329 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2010 | 2837 | 0.100 |
Why?
|
| Forelimb | 1 | 2011 | 122 | 0.100 |
Why?
|
| Desmin | 1 | 2010 | 130 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1950 | 0.090 |
Why?
|
| Homozygote | 4 | 2017 | 1777 | 0.090 |
Why?
|
| Cells, Cultured | 12 | 2021 | 19223 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
| Motion | 1 | 2014 | 797 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2018 | 496 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1707 | 0.090 |
Why?
|
| Quality of Life | 2 | 2022 | 12730 | 0.090 |
Why?
|
| Neuromuscular Junction | 1 | 2012 | 397 | 0.090 |
Why?
|
| Multigene Family | 4 | 2002 | 1102 | 0.090 |
Why?
|
| COS Cells | 2 | 2010 | 1160 | 0.090 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2010 | 61 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1589 | 0.090 |
Why?
|
| Cell Fusion | 2 | 2006 | 297 | 0.090 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2018 | 1442 | 0.090 |
Why?
|
| Sepsis | 1 | 2023 | 2589 | 0.090 |
Why?
|
| Tissue Distribution | 5 | 2019 | 2335 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11470 | 0.090 |
Why?
|
| Ribosome Subunits, Large | 1 | 2008 | 5 | 0.090 |
Why?
|
| Ribosome Subunits, Small | 1 | 2008 | 5 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3020 | 0.090 |
Why?
|
| Dinucleoside Phosphates | 1 | 1989 | 74 | 0.090 |
Why?
|
| Cohort Studies | 9 | 2022 | 40450 | 0.080 |
Why?
|
| Facies | 2 | 2020 | 197 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2013 | 3127 | 0.080 |
Why?
|
| Troponin | 1 | 2013 | 524 | 0.080 |
Why?
|
| Cell Transformation, Viral | 2 | 1990 | 565 | 0.080 |
Why?
|
| Mitochondria, Muscle | 2 | 2010 | 171 | 0.080 |
Why?
|
| Cloning, Molecular | 8 | 2001 | 4322 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2021 | 1586 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2183 | 0.080 |
Why?
|
| Physical Fitness | 2 | 2003 | 732 | 0.080 |
Why?
|
| Founder Effect | 1 | 2009 | 190 | 0.080 |
Why?
|
| Genes, Viral | 2 | 1986 | 718 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2187 | 0.080 |
Why?
|
| Longitudinal Studies | 6 | 2022 | 13921 | 0.080 |
Why?
|
| DNA | 13 | 2008 | 7289 | 0.080 |
Why?
|
| Blotting, Southern | 6 | 1993 | 803 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3504 | 0.080 |
Why?
|
| Hand Strength | 1 | 2011 | 444 | 0.080 |
Why?
|
| Myocardium | 3 | 2014 | 4775 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2014 | 728 | 0.080 |
Why?
|
| Genetic Markers | 8 | 2004 | 2633 | 0.080 |
Why?
|
| Serotonin | 2 | 2009 | 1024 | 0.080 |
Why?
|
| DNA, Complementary | 5 | 2004 | 2049 | 0.080 |
Why?
|
| Enzymes | 1 | 2009 | 266 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2004 | 2505 | 0.080 |
Why?
|
| Myositis, Inclusion Body | 1 | 2009 | 147 | 0.080 |
Why?
|
| Polymyositis | 1 | 2007 | 74 | 0.080 |
Why?
|
| Cell Count | 3 | 2012 | 1831 | 0.070 |
Why?
|
| Models, Biological | 3 | 2018 | 9581 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 1912 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2019 | 4282 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1655 | 0.070 |
Why?
|
| Middle Aged | 27 | 2021 | 213127 | 0.070 |
Why?
|
| Introns | 1 | 2009 | 991 | 0.070 |
Why?
|
| Cell Separation | 3 | 2011 | 1749 | 0.070 |
Why?
|
| Defective Viruses | 1 | 1986 | 112 | 0.070 |
Why?
|
| Critical Illness | 1 | 2019 | 2665 | 0.070 |
Why?
|
| Pediatrics | 2 | 2019 | 3462 | 0.070 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 62 | 0.070 |
Why?
|
| Personal Autonomy | 2 | 2019 | 297 | 0.070 |
Why?
|
| Fibroblasts | 5 | 2019 | 4143 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 3770 | 0.070 |
Why?
|
| Mortality | 1 | 2017 | 2857 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2006 | 78 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 1986 | 295 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2018 | 721 | 0.070 |
Why?
|
| Case-Control Studies | 7 | 2016 | 21719 | 0.070 |
Why?
|
| Epilepsy | 2 | 2018 | 3301 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 2842 | 0.070 |
Why?
|
| Fibrosis | 4 | 1998 | 2026 | 0.070 |
Why?
|
| Transgenes | 2 | 2021 | 1009 | 0.070 |
Why?
|
| Interferon-beta | 1 | 2007 | 323 | 0.070 |
Why?
|
| Receptors, Serotonin | 1 | 2006 | 210 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2015 | 3731 | 0.070 |
Why?
|
| Genetic Research | 2 | 2017 | 174 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3649 | 0.070 |
Why?
|
| Erythroid Precursor Cells | 1 | 2006 | 218 | 0.070 |
Why?
|
| Fatigue | 1 | 2013 | 1526 | 0.070 |
Why?
|
| Telephone | 2 | 2020 | 617 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2021 | 77098 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2005 | 2267 | 0.060 |
Why?
|
| Hematopoiesis | 2 | 2012 | 2066 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 1195 | 0.060 |
Why?
|
| Dermatomyositis | 1 | 2007 | 223 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 689 | 0.060 |
Why?
|
| Down-Regulation | 4 | 2009 | 3001 | 0.060 |
Why?
|
| Membrane Proteins | 5 | 2012 | 7873 | 0.060 |
Why?
|
| Syndrome | 4 | 2018 | 3248 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3839 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 2021 | 1613 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1740 | 0.060 |
Why?
|
| Immunoblotting | 6 | 2010 | 1683 | 0.060 |
Why?
|
| Species Specificity | 2 | 2021 | 2479 | 0.060 |
Why?
|
| Phylogeny | 1 | 2012 | 2797 | 0.060 |
Why?
|
| Binding Sites | 6 | 2010 | 6115 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1204 | 0.060 |
Why?
|
| Motor Activity | 2 | 2012 | 2714 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2005 | 175 | 0.060 |
Why?
|
| Software | 1 | 2018 | 4434 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2017 | 10248 | 0.060 |
Why?
|
| Postmortem Changes | 1 | 2004 | 125 | 0.060 |
Why?
|
| Selenium | 1 | 2006 | 402 | 0.060 |
Why?
|
| Culture Media | 1 | 1986 | 902 | 0.060 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2023 | 17 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2594 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2005 | 238 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4628 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2007 | 2713 | 0.060 |
Why?
|
| Growth Substances | 1 | 1986 | 783 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2007 | 895 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2021 | 971 | 0.060 |
Why?
|
| Paraproteinemias | 1 | 2006 | 247 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 766 | 0.060 |
Why?
|
| Alleles | 6 | 2019 | 6931 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2006 | 2513 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2021 | 2968 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2019 | 23320 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2011 | 1882 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15530 | 0.050 |
Why?
|
| Diagnosis, Differential | 5 | 2018 | 12958 | 0.050 |
Why?
|
| Glycogen | 1 | 2003 | 260 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 9735 | 0.050 |
Why?
|
| France | 1 | 2023 | 517 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2001 | 366 | 0.050 |
Why?
|
| Australia | 2 | 2003 | 1167 | 0.050 |
Why?
|
| Syncope | 3 | 2002 | 429 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 1998 | 895 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2001 | 1159 | 0.050 |
Why?
|
| RNA | 4 | 2005 | 2747 | 0.050 |
Why?
|
| Appendicitis | 1 | 2008 | 644 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3081 | 0.050 |
Why?
|
| Fetus | 3 | 2006 | 1879 | 0.050 |
Why?
|
| United States | 4 | 2023 | 69693 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 2 | 2018 | 894 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2001 | 462 | 0.050 |
Why?
|
| Germany | 1 | 2023 | 860 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7276 | 0.050 |
Why?
|
| Sialorrhea | 1 | 2021 | 25 | 0.050 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2002 | 117 | 0.050 |
Why?
|
| Probability | 3 | 2020 | 2502 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 508 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1887 | 0.050 |
Why?
|
| Respiratory Insufficiency | 2 | 2017 | 1199 | 0.050 |
Why?
|
| RNA Splicing | 2 | 2018 | 907 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2021 | 81 | 0.050 |
Why?
|
| Wheelchairs | 1 | 2021 | 77 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 836 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2007 | 2372 | 0.050 |
Why?
|
| Hemangioma | 1 | 2005 | 737 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2014 | 8436 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2001 | 269 | 0.050 |
Why?
|
| Protein Binding | 3 | 2024 | 9387 | 0.040 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 427 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2017 | 657 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2001 | 374 | 0.040 |
Why?
|
| Body Weight | 1 | 2011 | 4664 | 0.040 |
Why?
|
| Eye Abnormalities | 1 | 2002 | 246 | 0.040 |
Why?
|
| Oncogenes | 1 | 1986 | 1263 | 0.040 |
Why?
|
| Cell Division | 2 | 2003 | 4564 | 0.040 |
Why?
|
| Myositis | 1 | 2002 | 251 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2020 | 153 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2022 | 446 | 0.040 |
Why?
|
| Models, Animal | 2 | 2017 | 2170 | 0.040 |
Why?
|
| North America | 1 | 2003 | 1249 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 908 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1999 | 170 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4200 | 0.040 |
Why?
|
| DNA, Satellite | 2 | 1996 | 69 | 0.040 |
Why?
|
| Rhabdomyolysis | 1 | 2020 | 150 | 0.040 |
Why?
|
| Aging | 3 | 2005 | 8626 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2001 | 319 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1999 | 287 | 0.040 |
Why?
|
| Siblings | 2 | 2019 | 854 | 0.040 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 1998 | 70 | 0.040 |
Why?
|
| Histone Code | 1 | 2019 | 163 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2020 | 309 | 0.040 |
Why?
|
| PAX2 Transcription Factor | 1 | 2018 | 80 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
| Exotropia | 1 | 1998 | 55 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2002 | 258 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2008 | 3455 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 922 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 1999 | 281 | 0.040 |
Why?
|
| Transfection | 5 | 2010 | 5892 | 0.040 |
Why?
|
| Leg | 1 | 2003 | 1110 | 0.040 |
Why?
|
| Harm Reduction | 1 | 2019 | 129 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2018 | 166 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 3639 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 23 | 0.040 |
Why?
|
| Chromatin | 1 | 1989 | 2917 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
| Strabismus | 2 | 2002 | 287 | 0.040 |
Why?
|
| Creatine Kinase | 2 | 1996 | 694 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 321 | 0.040 |
Why?
|
| Tetany | 1 | 2016 | 13 | 0.040 |
Why?
|
| Neoplasms | 1 | 2006 | 21596 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2021 | 400 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 747 | 0.040 |
Why?
|
| Sports | 1 | 2003 | 686 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2021 | 752 | 0.040 |
Why?
|
| Integrins | 1 | 2021 | 845 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2017 | 136 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2017 | 65 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 676 | 0.040 |
Why?
|
| Isomerism | 1 | 1996 | 201 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 405 | 0.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2000 | 359 | 0.040 |
Why?
|
| Placenta | 1 | 2005 | 1694 | 0.040 |
Why?
|
| DNA Probes | 4 | 1990 | 560 | 0.040 |
Why?
|
| Insurance Claim Review | 1 | 2021 | 720 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 15494 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1999 | 1245 | 0.030 |
Why?
|
| Electron Transport | 1 | 2017 | 211 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 561 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 6974 | 0.030 |
Why?
|
| Globins | 1 | 2017 | 415 | 0.030 |
Why?
|
| Mitochondria | 2 | 2021 | 3520 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2005 | 2260 | 0.030 |
Why?
|
| Alternative Splicing | 2 | 2014 | 1118 | 0.030 |
Why?
|
| Glucuronidase | 1 | 2017 | 207 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2016 | 87 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3497 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2017 | 238 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2017 | 468 | 0.030 |
Why?
|
| Aged | 13 | 2019 | 162944 | 0.030 |
Why?
|
| Reflex | 1 | 2017 | 365 | 0.030 |
Why?
|
| Brain | 8 | 2005 | 26343 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2022 | 53187 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 763 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 230 | 0.030 |
Why?
|
| Amblyopia | 1 | 1997 | 142 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2021 | 8297 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2007 | 19862 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1998 | 595 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1989 | 0.030 |
Why?
|
| Action Potentials | 2 | 2017 | 1814 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 676 | 0.030 |
Why?
|
| Cyclin E | 1 | 2015 | 172 | 0.030 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.030 |
Why?
|
| Confidentiality | 1 | 2019 | 609 | 0.030 |
Why?
|
| Reference Values | 4 | 2006 | 4982 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1995 | 68 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2006 | 4214 | 0.030 |
Why?
|
| Patient Selection | 2 | 2018 | 4214 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 707 | 0.030 |
Why?
|
| New Hampshire | 1 | 1994 | 172 | 0.030 |
Why?
|
| Ion Channel Gating | 2 | 2009 | 437 | 0.030 |
Why?
|
| Apolipoprotein A-II | 1 | 1994 | 39 | 0.030 |
Why?
|
| Birefringence | 1 | 2013 | 56 | 0.030 |
Why?
|
| Neurons | 3 | 2009 | 9325 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 913 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 1999 | 1995 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1994 | 136 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2014 | 87 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2017 | 370 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2019 | 6142 | 0.030 |
Why?
|
| Scoliosis | 1 | 2020 | 719 | 0.030 |
Why?
|
| Freezing | 1 | 2014 | 303 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 931 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
| Glioma | 1 | 1988 | 3388 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10472 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 594 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1998 | 1062 | 0.030 |
Why?
|
| Electrocardiography | 4 | 2002 | 6440 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2021 | 1827 | 0.030 |
Why?
|
| Ontario | 1 | 1994 | 381 | 0.030 |
Why?
|
| Mitochondrial Diseases | 1 | 2017 | 321 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 462 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 963 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 1546 | 0.030 |
Why?
|
| Motivation | 1 | 2022 | 1968 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2012 | 810 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 320 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2017 | 705 | 0.030 |
Why?
|
| PAX7 Transcription Factor | 1 | 2012 | 53 | 0.030 |
Why?
|
| Pyridostigmine Bromide | 1 | 2012 | 31 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2023 | 62966 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 596 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 1895 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2004 | 2003 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6382 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 462 | 0.030 |
Why?
|
| Family Health | 2 | 2012 | 1282 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9941 | 0.030 |
Why?
|
| Informed Consent | 1 | 2018 | 991 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 461 | 0.030 |
Why?
|
| Spectrin | 1 | 1992 | 177 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2017 | 851 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 1391 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 814 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2896 | 0.030 |
Why?
|
| Antibodies | 2 | 1997 | 2459 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 142 | 0.020 |
Why?
|
| Skin | 2 | 2019 | 4353 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2012 | 238 | 0.020 |
Why?
|
| Retina | 1 | 2002 | 2611 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3617 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1675 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 474 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 8425 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2019 | 1100 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1086 | 0.020 |
Why?
|
| Plasmids | 2 | 1986 | 2305 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2014 | 678 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2638 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 749 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1606 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2018 | 1035 | 0.020 |
Why?
|
| Mothers | 1 | 2021 | 2163 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 1992 | 388 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2039 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2010 | 64 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 778 | 0.020 |
Why?
|
| Quinazolines | 1 | 2017 | 1355 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1995 | 1122 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2010 | 175 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 430 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 2255 | 0.020 |
Why?
|
| Aged, 80 and over | 5 | 2014 | 57683 | 0.020 |
Why?
|
| Rabbits | 1 | 1996 | 4886 | 0.020 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1989 | 25 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9846 | 0.020 |
Why?
|
| Mitosis | 1 | 2015 | 1208 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 24913 | 0.020 |
Why?
|
| Cadherins | 1 | 2014 | 906 | 0.020 |
Why?
|
| Fluorescence | 1 | 1992 | 751 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2021 | 1895 | 0.020 |
Why?
|
| Cricetinae | 2 | 1995 | 2471 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2867 | 0.020 |
Why?
|
| Factor IX | 1 | 1989 | 77 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 3769 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2074 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1057 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2016 | 6452 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1988 | 14 | 0.020 |
Why?
|
| ras Proteins | 1 | 2014 | 1060 | 0.020 |
Why?
|
| Extremities | 1 | 2014 | 865 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1301 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 1999 | 4465 | 0.020 |
Why?
|
| Calpain | 1 | 2009 | 150 | 0.020 |
Why?
|
| Decision Making | 1 | 2022 | 3869 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2021 | 2493 | 0.020 |
Why?
|
| Emotions | 2 | 2016 | 2657 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 172 | 0.020 |
Why?
|
| Guanine | 1 | 1989 | 274 | 0.020 |
Why?
|
| Cytosine | 1 | 1989 | 216 | 0.020 |
Why?
|
| Child Development | 1 | 2019 | 2222 | 0.020 |
Why?
|
| Homeostasis | 2 | 2009 | 3335 | 0.020 |
Why?
|
| Sarcolemma | 2 | 1999 | 66 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1723 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2017 | 1852 | 0.020 |
Why?
|
| Risk Factors | 4 | 2021 | 72145 | 0.020 |
Why?
|
| Neural Crest | 1 | 1990 | 275 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1801 | 0.020 |
Why?
|
| Health Status | 1 | 2021 | 4030 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2680 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 936 | 0.020 |
Why?
|
| Jews | 1 | 2009 | 385 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 584 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1760 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2851 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1683 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1989 | 625 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1994 | 1899 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2008 | 548 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 340 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2006 | 54 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Azacitidine | 1 | 1988 | 347 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2010 | 1263 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2924 | 0.020 |
Why?
|
| Meningioma | 1 | 1995 | 1209 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 2906 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2010 | 880 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 2749 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12220 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2011 | 804 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 2440 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1995 | 1241 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6534 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1990 | 514 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 55 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 252 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2895 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1986 | 258 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 2005 | 62 | 0.020 |
Why?
|
| Mice, Inbred mdx | 1 | 2005 | 90 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1179 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2009 | 621 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2005 | 240 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1728 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2005 | 313 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1986 | 207 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1994 | 1340 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 977 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2008 | 689 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1992 | 1811 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1990 | 903 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 436 | 0.020 |
Why?
|
| Internet | 1 | 2017 | 3062 | 0.020 |
Why?
|
| Epithelium | 1 | 1990 | 1680 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1986 | 362 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2012 | 3493 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 322 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3862 | 0.020 |
Why?
|
| Karyotyping | 1 | 1986 | 1243 | 0.020 |
Why?
|
| Centrosome | 1 | 2005 | 201 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 939 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1684 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2019 | 7716 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2003 | 45 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3306 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4839 | 0.010 |
Why?
|
| RNA Probes | 1 | 2003 | 113 | 0.010 |
Why?
|
| Statistical Distributions | 1 | 2003 | 64 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1990 | 1232 | 0.010 |
Why?
|
| Adenoma | 1 | 1994 | 2168 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 970 | 0.010 |
Why?
|
| Xenopus | 1 | 2005 | 712 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 2224 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9305 | 0.010 |
Why?
|
| Epitopes | 1 | 1989 | 2569 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10372 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 319 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3444 | 0.010 |
Why?
|
| Ocular Hypotension | 1 | 2002 | 22 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 35342 | 0.010 |
Why?
|
| Astrocytes | 1 | 1990 | 1266 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5872 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 1309 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4823 | 0.010 |
Why?
|
| Gene Components | 1 | 2001 | 29 | 0.010 |
Why?
|
| Muridae | 1 | 2001 | 61 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3923 | 0.010 |
Why?
|
| Prognosis | 2 | 2001 | 29010 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3691 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4553 | 0.010 |
Why?
|
| Glycine | 1 | 2005 | 671 | 0.010 |
Why?
|
| Depression | 1 | 2021 | 7733 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 718 | 0.010 |
Why?
|
| Cadaver | 1 | 2005 | 1333 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1996 | 4030 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2003 | 316 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1835 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5978 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
| Endocytosis | 1 | 2005 | 983 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1866 | 0.010 |
Why?
|
| Physical Endurance | 1 | 2003 | 370 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 815 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5975 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 6313 | 0.010 |
Why?
|
| Oocytes | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 963 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1991 | 878 | 0.010 |
Why?
|
| Sex Factors | 2 | 2005 | 10392 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1991 | 5867 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
| Neuropilin-1 | 1 | 1999 | 90 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2002 | 548 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5425 | 0.010 |
Why?
|
| Running | 1 | 2003 | 478 | 0.010 |
Why?
|
| Utrophin | 1 | 1997 | 14 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4211 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13853 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1999 | 318 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1659 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 3133 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 7141 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3490 | 0.010 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 1997 | 3 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1998 | 829 | 0.010 |
Why?
|
| Neuronal Apoptosis-Inhibitory Protein | 1 | 1996 | 12 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 2890 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4566 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1996 | 118 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 893 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1076 | 0.010 |
Why?
|
| Proteomics | 1 | 2009 | 3618 | 0.010 |
Why?
|
| Ion Channels | 1 | 2001 | 1056 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1995 | 69 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3711 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2008 | 2301 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2006 | 2941 | 0.010 |
Why?
|
| Time Factors | 2 | 2014 | 40054 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1996 | 403 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1692 | 0.010 |
Why?
|
| Macrophages | 1 | 1990 | 5655 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 1239 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1996 | 8829 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1995 | 351 | 0.010 |
Why?
|
| Proteolipids | 1 | 1994 | 117 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 9274 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1996 | 800 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4455 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 491 | 0.010 |
Why?
|
| Genome | 1 | 2001 | 1803 | 0.010 |
Why?
|
| Glaucoma | 1 | 2002 | 1152 | 0.010 |
Why?
|
| Methylation | 1 | 1995 | 1107 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2001 | 1541 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 1937 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1998 | 1167 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5948 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1995 | 981 | 0.010 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20774 | 0.010 |
Why?
|
| Genomic Library | 1 | 1991 | 193 | 0.010 |
Why?
|
| Rats | 2 | 1998 | 24265 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1998 | 2614 | 0.010 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1989 | 15 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1990 | 570 | 0.010 |
Why?
|
| Reading Frames | 1 | 1989 | 19 | 0.010 |
Why?
|
| Sarcoma | 1 | 2001 | 1895 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6608 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1992 | 515 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1991 | 1094 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1994 | 1758 | 0.010 |
Why?
|
| Synapses | 1 | 1998 | 1724 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1989 | 841 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 2000 | 2536 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 8300 | 0.000 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2906 | 0.000 |
Why?
|
| Survival Rate | 1 | 2001 | 12773 | 0.000 |
Why?
|
| Sleep | 1 | 2001 | 4604 | 0.000 |
Why?
|
| Pregnancy | 1 | 2006 | 29087 | 0.000 |
Why?
|
| Exercise | 1 | 2001 | 5611 | 0.000 |
Why?
|
| Hippocampus | 1 | 1997 | 3661 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 13019 | 0.000 |
Why?
|
| Kidney | 1 | 1995 | 7167 | 0.000 |
Why?
|